BioDuro-Sundia vs ChemDiv

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bioduro-sundia/chemdiv

Category	BioDuro-Sundia	ChemDiv
Listed site	cro	cro
Summary	BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.	ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.
Services	Discovery Research Target Identification & Validation High-Throughput Screening Computational & In-Silico Drug Discovery Medicinal Chemistry In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vitro Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Specialized & Large-Animal Models Preclinical In Vivo Studies Bioanalysis Biomarker Assays Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies Translational Research US FDA Regulatory Strategy China NMPA Regulatory Strategy Regulatory Affairs Immunogenicity Assays (ADA / NAb) Oncology Specialty Services Immunology & Inflammation Services	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery In Vitro Pharmacology In Vitro ADME / DMPK In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vitro Studies Preclinical In Vivo Studies Safety Pharmacology GLP Toxicology Specialized & Large-Animal Models Translational Research
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) Peptide	Small Molecule Antibody-Drug Conjugate (ADC) Oligonucleotide Gene Therapy
Indications	Oncology Immunology Neurology Metabolic Respiratory	Oncology Immunology Neurology Metabolic Cardiovascular Infectious Disease
Locations	Headquarters, Irvine, California, United States	Headquarters, San Diego, CA, USA Representative - South Korea, Seongnam-si, Gyeongi-do, South Korea Representative - Japan, Tokyo, Tokyo, Japan Representative - China, Shanghai, Shanghai, China
Certifications	Data not yet provided.	GLP · Identifier: GLP compliant CMP · Identifier: CMP compliant
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.